Skip to main content

01.05.2019 | Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors) | Ausgabe 5/2019

Current Allergy and Asthma Reports 5/2019

Evaluating Penicillin Allergies Without Skin Testing

Current Allergy and Asthma Reports > Ausgabe 5/2019
Taylor A. Banks, Mark Tucker, Eric Macy
Wichtige Hinweise
This article is part of the Topical Collection on Anaphylaxis and Drug Allergy

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.


Purpose of Review

An unconfirmed penicillin allergy is known to confer significant risk to patients. Only a small minority of patients labeled with penicillin allergy will be confirmed to be hypersensitive with the current reference standard test, an oral amoxicillin therapeutic dose challenge. Skin testing has been recommended prior to oral challenges to reduce the risk of severe acute challenge reactions. The rate of severe acute anaphylactic reactions with oral amoxicillin is currently extremely low. Unfortunately, penicillin skin testing, as commonly performed, has a high rate of false positive results.

Recent Findings

Encouraging skin testing in all individuals with an unconfirmed penicillin allergy, prior to a confirmatory oral challenge, would be technically difficult, make testing all individuals with an unconfirmed penicillin allergy very unlikely, and ultimately increase the risk to patients because of suboptimal antibiotic use. Most patients, who are appropriate candidates for a direct oral amoxicillin challenge, to confirm current penicillin tolerance, can be safely identified by their clinical histories. Higher risk individuals, those with a history of anaphylaxis or other acute onset potentially IgE-mediated reaction such as hives within 6 h of the first dose of the last course of a penicillin, may benefit from properly performed puncture and intradermal skin testing, using commercially available penicilloyl-polylysine, prior to an oral challenge, if skin test negative.


Direct oral amoxicillin challenges in low-risk individuals are well accepted by patients and a safe and effective part of penicillin allergy delabeling.

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

e.Med Interdisziplinär

Mit e.Med Interdisziplinär erhalten Sie Zugang zu allen CME-Fortbildungen und Fachzeitschriften auf

Über diesen Artikel

Weitere Artikel der Ausgabe 5/2019

Current Allergy and Asthma Reports 5/2019 Zur Ausgabe

Rhinosinusitis (J Mullol, Section Editor)

Osteitis in Chronic Rhinosinusitis

Basic and Applied Science (I Lewkowich, Section Editor)

Exosomes in Allergic Airway Diseases

Immunotherapy and Immunomodulators (B Vickery, Section Editor)

Microbial Adjuncts for Food Allergen Immunotherapy

Anaphylaxis and Drug Allergy (DA Khan and M Castells, Section Editors)

Chlorhexidine Allergy: On the Rise and Often Overlooked

Basic and Applied Science (I Lewkowich, Section Editor)

Th9 Cells in Allergic Disease

Neu im Fachgebiet HNO

Mail Icon II Newsletter

Bestellen Sie unseren kostenlosen Newsletter Update HNO und bleiben Sie gut informiert – ganz bequem per eMail.